Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Hyebin Ko"'
Autor:
Won Oh Choi, Young Jae Jung, Minyoung Kim, Hoyun Kim, Jingjing Li, Hyebin Ko, Hong-In Lee, Hye Jin Lee, Jungkyu K. Lee
Publikováno v:
ACS Omega, Vol 8, Iss 43, Pp 40277-40286 (2023)
Externí odkaz:
https://doaj.org/article/d257b108125a4465b100a7d5f94432aa
Publikováno v:
Cell & Bioscience, Vol 14, Iss 1, Pp 1-18 (2024)
Abstract Background In vitro disease modeling enables translational research by providing insight into disease pathophysiology and molecular mechanisms, leading to the development of novel therapeutics. Nevertheless, in vitro systems have limitations
Externí odkaz:
https://doaj.org/article/8b1331897aa947a7a5d5ea4789adae89
Autor:
Joseph B. Nganga, Young Jae Jung, Yunpei Si, Minyoung Kim, Hyebin Ko, Gil Tae Hwang, Hye Jin Lee, Hong-In Lee, Jungkyu K. Lee
Publikováno v:
Dyes and Pigments. 200:110163
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ec2fa90038484b176a971587ea77655b
https://doi.org/10.1016/j.dyepig.2022.110163
https://doi.org/10.1016/j.dyepig.2022.110163
Autor:
Soo-Been Jeon, Hyebin Koh, A-Reum Han, Jieun Kim, Sunghun Lee, Jae-Ho Lee, Seung-Soon Im, Young-sup Yoon, Jong-Hee Lee, Ji Yoon Lee
Publikováno v:
npj Regenerative Medicine, Vol 8, Iss 1, Pp 1-16 (2023)
Abstract Red blood cell (RBC) generation from human pluripotent stem cells (PSCs) offers potential for innovative cell therapy in regenerative medicine as well as developmental studies. Ex vivo erythropoiesis from PSCs is currently limited by the low
Externí odkaz:
https://doaj.org/article/2b0edcb017f7431d97ebf6e3c32a580e
Autor:
Ju-Hyun An, Hyebin Koh, Yujin Ahn, Jieun Kim, A-Reum Han, Ji Yoon Lee, Sun-Uk Kim, Jong-Hee Lee
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 10 (2022)
Universally acceptable donor cells have been developed to address the unmet need for immunotypically matched materials for regenerative medicine. Since forced expression of hypoimmunogenic genes represses the immune response, we established universal
Externí odkaz:
https://doaj.org/article/bd782098bb05415cb2c2832151ef404e
Publikováno v:
Stem Cell Research, Vol 60, Iss , Pp 102674- (2022)
Induced pluripotent stem cells (iPSCs) hold great promise as a potential source for regenerative medicine. Umbilical cord blood (UCB) cells possess a high level of stem cells, exhibit less immune rejection, and have fewer DNA mutations and, thus, are
Externí odkaz:
https://doaj.org/article/cf71d77773684d08813625c5ec356c11
Publikováno v:
Stem Cell Research, Vol 57, Iss , Pp 102587- (2021)
Induced pluripotent stem cell (iPS) technology may be advantageous for the study of genetic aberrations in terms of recapitulating the full manifestation of pathological features in vitro, identifying underlying pathways, and developing personalized
Externí odkaz:
https://doaj.org/article/cf8357ab7364481384cd5ca460375d10
Publikováno v:
Stem Cell Research, Vol 51, Iss , Pp 102199- (2021)
Human induced pluripotent stem cells with indefinite propagation in vitro provide a potential donor source of cells including erythroid cells for human therapy. Since group O D-negative (RhD−) blood cells are considered as universal donors for tran
Externí odkaz:
https://doaj.org/article/672286c1c62945009465a5e16a8e22c0
Autor:
Yujin Ahn, Ju-Hyun An, Hae-Jun Yang, Dong Gil Lee, Jieun Kim, Hyebin Koh, Young-Ho Park, Bong-Seok Song, Bo-Woong Sim, Hong J. Lee, Jong-Hee Lee, Sun-Uk Kim
Publikováno v:
Cells, Vol 10, Iss 8, p 2036 (2021)
Vascularization of tissues, organoids and organ-on-chip models has been attempted using endothelial cells. However, the cultured endothelial cells lack the capacity to interact with other somatic cell types, which is distinct from developing vascular
Externí odkaz:
https://doaj.org/article/237725e7f10841d3bdb4d1ba4d04d108